Polysaccharides as nanocarriers for therapeutic applications

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 2149-2172

  Singh, Deepti ^a   Han, Sung Soo ^a   Shin, Eun Joo ^b  

^a Yeungnam University   (South Korea)

^b Dong A University   (South Korea)

Author keywords

Cellular internalization; Clathrin; Intracellular trafficking; Nanocarriers; Polysaccharides

Indexed keywords

AUTOMOBILE MANUFACTURE; BIOCOMPATIBILITY; DNA; DRUG DELIVERY; ENZYME INHIBITION; MATERIALS PROPERTIES; POLYMERS; PROTEINS;

CELLULAR INTERNALIZATION; CLATHRINS; DRUG DELIVERY VEHICLES; INTRACELLULAR TRAFFICKING; NANO-CARRIERS; NATURAL POLYSACCHARIDE; PHYSICOCHEMICAL PROPERTY; THERAPEUTIC APPLICATION;

POLYSACCHARIDES;

ANTINEOPLASTIC AGENT; CLATHRIN; DNA; DRUG VEHICLE; NANOCARRIER; POLYMER; POLYSACCHARIDE; RNA; DRUG CARRIER; NANOPARTICLE;

CELL MIGRATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; COST EFFECTIVENESS ANALYSIS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DNA INTERACTION; DRUG EFFICACY; ENDOSOME; GENE TARGETING; HUMAN; INTERNALIZATION; NANOFABRICATION; NONHUMAN; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; REVIEW; RNA BINDING; STATIC ELECTRICITY; SURFACE CHARGE; ANIMAL; CHEMISTRY; NANOTECHNOLOGY;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; POLYSACCHARIDES;

EID: 84904894270     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1958     Document Type: Review

References (199)

1. L. Jabr-Milane, L. Vlerken, H. Devalapally, D. Shenoy, S. Komareddy, M. Bhavsar, and M. Amiji, Multi-functional nanocarriers for targeted delivery of drugs and genes. J. Control Release 130, 121 (2008).
2. W. Jong and P. Borm, Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine 3, 133 (2008).
3. R. Gaspar, V. Préat, F. Opperdoes, and M. Roland, Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: Activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm. Res. 9, 782 (1992).
4. R. Tyagi, S. Lala, A. K. Verma, A. K. Nandy, S. B. Mahato, A. Maitra, and M. K. Basu, Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J. Drug Target 13, 161 (2005).
5. A. Vonarbourg, C. Passirani, P. Saulnier, and J. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27, 4356 (2006).
6. A. Cerletti, J. Drewe, G. Fricker, A. Eberle, and J. Huwyler, Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J. Drug Target 8, 435 (2000).
7. C. E. Soma, C. Dubernet, G. Barratt, F. Nemati, M. Appel, S. Benita, and P. Couvreur, Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumour cells after their capture by macrophages. Pharm. Res. 16, 1710 (1999).
8. Z. P. Xu, M. Niebert, K. Porazik, T. L. Walker, H. M. Cooper, A. P. J. Middelberg, P. P. Gray, P. F. Bartlett, and G. Q. Lu, Subcellular compartment targeting of layered double hydroxide nanoparticles. J. Control Release 130, 86 (2008).
9. M. K. Gummerloch and E. A. Neuwalt, Physiology and pharmacology of the blood-brain barrier, Handbook of Experimental Pharmacology, edited by M. W. B. Bradbury, Springer, Berlin (1992), Vol. 103, pp. 525-542.
10. C. S. Cho, Y. I. Jeong, T. Ishihara, R. Takei, J. U. Park, and K. H. Park, Simple preparation of nanoparticles coated with carbohydratecarrying polymers. Biomaterials 18, 323 (1996).
11. A. Maruyama, T. Ishihara, N. Adachi, and T. Akaike, Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier. Biomaterials 15, 1035 (1994).
12. S. Deguchi, K. Akiyoshi, and J. Sunamoto, Solution property of hydrophobized pullulan conjugated with poly(ethylene pxide)-poly(propylene oxide) block copolymer. Formation of nanoparticlesand their thermosensitivity. Macromol Rapid Comm. 15, 705 (1994).
13. K. Akiyoshi and J. Sunamoto, Supramolecular assembly of hydrophobized polysaccharides. Supramol. Sci. 3, 157 (1996).
14. K. Akiyoshi, S. Kobayashi, S. Shichibe, D. Mix, M. Baudys, S. W. Kim, and J. Sunamoto, Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J. Control Release 54, 313 (1998).
15. Y. Normura, M. Ikeda, N. Yamaguchi, Y. Aoyama, and K. Akiyoshi, Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. Fed. Eur. Biochem. Soc. Lett. 553, 271 (2003).
16. K. Na, T. B. Lee, K. H. Park, E. K. Shin, Y. B. Lee, and H. K. Choi, Selfassembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18, 165 (2003).
17. M. Francis, L. Lavoie, F. Winnik, and J. C. Leroux, Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkylether polymeric micelles. Eur. J. Pharm. Sci. 56, 337 (2003).
18. C. E. Soma, C. Dubernet, G. Barratt, F. Nemati, M. Appel, S. Benita, and P. Couvreur, Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumour cells after their capture by macrophages. Pharm. Res. 16, 1710 (1999).
19. K. Park, Polysaccharide-based near-infrared fluorescence nanoprobes for cancer diagnosis. Quant. Imaging Med. Surg. 2, 106 (2012).
20. S. Dumitriu, Polysaccharides as biomaterials, Polymeric Biomaterials, edited by S. Dumitriu, Marcel Dekker, New York (2001), pp. 1-61.
21. K. Na, K. H. Park, S. W. Kim, and Y. H. Bae, Self-assembled hydrogel nanoparticles from curdlan derivatives: Characterization, anti-cancer drug release and interaction with hepatoma cell line (HepG2). J. Control Release 69, 225 (2000).
22. J. C. Olivier, C. Vauthier, M. Taverna, D. Ferrier, and P. Couvreur, Preparation and characterization of biodegradable poly(isobutylcyanoacrylate) nanoparticles with the surface modified by theadsorption of proteins. Colloid Surface B 4, 349 (1995).
23. J. C. Olivier, C. Vauthier, M. Taverna, F. Puisieux, D. Ferrier, and P. Couvreur, Stability of orosumucoid-coated polyisobutylcyanoacrylatenanoparticles in the presence of serum. J. Control Release 40, 157 (1996).
24. C. Chouly, D. Pouliquen, I. Lucet, J. J. Jeune, and P. Jallet, Development of superparamagnetic nanoparticles for MRI: Effect of particle size,charge and surface nature on biodistribution. J. Microencapsul. 3, 245 (1996).
25. C. Rouzes, R. Gref, M. Leonard, A. D. S. Delgado, and E. Dellacherie, Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique. J. Biomed. Mater. Res. A 50, 557 (2000).
26. C. Lemarchand, P. Couvreur, M. Besnard, D. Costantini, and R. Gref, Novel polyester-polysaccharide nanoparticles. Pharm. Res. 20, 1284 (2003).
27. V. R. Sinha and R. Kumria, Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224, 19 (2001).
28. A. D. Baldwin and K. L. Kiick, Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers 94, 128 (2010).
29. A. Cesàro, B. Bellich, and M. Borgogna, Biophysical functionality in polysaccharides: From Lego-blocks to nano-particles. Eur. Biophys. J. 41, 379 (2012).
30. S. C. Yang, H. X. Ge, Y. Hu, X. Q. Jiang, and C. Z. Yang, Formation of positively charged poly (butyl cyanoacrylate) nanoparticles stabilized with chitosan. Colloid Polym. Sci. 278, 285 (2000).
31. A. N. Laskovski (ed.), Biomedical Engineering, Trends in Materials Science, InTech Publisher, Croatia (2011).
32. E. A. Stepnova, V. E. Tikhonov, T. A. Babushkina, T. P. limova, E. V. Vorontsov, V. G. Babak, S. A. Lopatin, and I. A. Yamskov, New approach to the quaternization of chitosan and its amphiphilic derivatives. Eur. Polym J. 43, 2414 (2007).
33. T. A. Sonia and C. P. Sharma, Chitosan and its derivatives for drug delivery perspective. Adv. Polym Sci. 243, 23 (2011).
34. N. Saranya, A. Moorthi, S. Saravanan, M. P. Devi, and N. Selvamurugan, Chitosan and its derivatives for gene delivery. Int. J. Biol. Macromol. 48, 234 (2011).
35. Y. Sun, S. Zhang, X. Peng, Z. Gong, X. Li, Z. Yuan, Y. Li, D. Zhang, and Y. Peng, Preparation, characterization and transfection efficacy of chitosan nanoparticles containing the intestinal trefoil factor gene. Mol. Biol. Rep. 39, 945 (2012).
36. S. Akhtar, M. D. Hughes, A. Khan, M. Bibby, M. Hussain, Q. Nawaz, J. Double, and P. Sayyed, The delivery of antisense therapeutics. Adv. Drug. Deliv. Rev. 44, 3 (2000).
37. S. D. Patil, D. G. Rhodes, and D. J. Burgess, DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS J. 7, E61 (2005).
38. J. Yao, Y. Fan, R. Du, J. Zhou, Y. Lu, W. Wang, J. Ren, and X. Sun, Amphoteric hyaluronic acid derivative for targeting gene delivery. Biomaterials 31, 9357 (2010).
39. T. Azzam and A. J. Domb, Current developments in gene transfection agents. Curr. Drug. Deliv. 1, 165 (2004).
40. R. G. Crystal, Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404 (1995).
41. F. D. Ledley, Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum. Gene. Ther. 6, 1129 (1995).
42. G. A. Pietersz, C. K. Tang, and V. Apostolopoulos, Structure and design of polycationic carriers for gene delivery. Mini. Rev. Med. Chem. 6, 1285 (2006).
43. T. Kimura, T. Yamaoka, R. Iwase, and A. Murakami, Structure/function relationship in the polyplexes containing cationic polypeptides for gene delivery. Nucleic Acids Res. Suppl. 1, 203 (2001).
44. C. Louise, Nonviral vectors. Methods. Mol. Biol. 333, 201 (2006).
45. D. Sahoo, S. Sahoo, P. Mohanty, S. Sasmal, and P. L. Nayak, Chitosan: A new versatile bio-polymer for various applications. Des. Monomers. Polym. 12, 377 (2009).
46. E. V. van Gaal, R. S. Oosting, R. van Eijk, M. Bakowska, D. Feyen, R. J. Kok, W. E. Hennink, D. J. Crommelin, and E. Mastrobattista, DNA nuclear targeting sequences for non-viral gene delivery. Pharm. Res. 28, 1707 (2011).
47. M. J. Tiera, Q. Shi, F. M. Winnik, and J. C. Fernandes, Polycationbased gene therapy: Current knowledge and new perspectives. Curr. Gene. Ther. 11, 288 (2011).
48. S. Boddohi and M. J. Kipper, Engineering nanoassemblies of polysaccharides. Adv. Mater. 22, 2998 (2010).
49. J. Kreuter, Nanoparticles-A historical perspective. Int. J. Pharm. 331, 1 (2007).
50. J. Kreuter and E. Liehl, Protection induced by inactivated influenza vaccines with polymethylmethacrylate adjuvants. Med. Microbiol. Immunol. 165, 111 (1978).
51. R. Lobenberg and J. Kreuter, Macrophage targeting of azidothymidine: A promising strategy for AIDS therapy. AIDS Res. Hum. Retroviruses. 12, 1709 (1996).
52. M. A. Zarbin, C. Montemagno, J. F. Leary, and R. Ritch. Nanotechnology in ophthalmology. Can. J. Ophthalmol. 45, 457 (2010).
53. S. S. Guterres, M. P. Alves, and A. R. Pohlmann, Polymeric nanoparticles, nanospheres and nanocapsules for cutaneous applications. Drug Target Insights 2, 147 (2007).
54. J. E. Shin, K. M. Shin, H. N. Lee, J. B. Nam, J. E. Jung, J. H. Ryu, J. H. Han, K.D. Suh, Y. J. Kim, J. W. Shim, J. O. Kim, S. H. Han, K. H. Char, Y. K. Kim, J. H. Chung, M. J. Lee, B. C. Kang, and J. W. Kim, Non-invasive transdermal delivery route using electrostatically interactive biocompatible nanocapsules. Adv. Mater. 22, 739 (2010).
55. P. Lertsutthiwong, P. Rojsitthisak, and U. Nimmannit, Preparation of turmeric oil-loaded chitosan-alginate biopolymeric nanocapsules. Mater. Sci. Eng. C, Biomim. Mater. Sens. Syst. 29, 856 (2009).
56. H. Ayame, N. Morimoto, and K. Akiyosh, Self-assembled cationic nanogels for intracellular protein delivery system. Bioconjugate Chem. 19, 882 (2008).
57. I. Yudovin-Farber, T. Azzam, E. Metzer, A. Taraboulos, and A. J. Domb, Cationic polysaccharides as antiprion agents. J. Med. Chem. 48, 1414 (2005).
58. K. Kunath, A. Von Harpe, D. Fischer, H. Petersen, U. Bickel, K. Voigt, and T. Kissel, Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Control Release 89, 113 (2003).
59. I. Honore, S. Grosse, N. Frison, F. Favatier, M. Monsigny, and I. Fajac, Transcription of plasmid DNA: Influence of plasmid DNA/polyethylenimine complex formation. J. Control Release 107, 537 (2005).
60. M. L. Read, S. Singh, Z. Ahmed, M. Stevenson, S. S. Briggs, D. Oupicky, L. B. Barrett, R. Spice, M. Kendall, M. Berry, J. A. Preece, A. Logan, and L. W. Seymour, A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. 24, 86 (2005).
61. J. J. Thomas, M. R Rekha, and C.P. Sharma. Dextran- glycidyltrimethylammonium chloride conjugate/DNA nanoplex: A potential non-viral and haemocompatible gene delivery system. Int. J. Pharm. 389, 195 (2011).
62. M. L. Forrest, N. Gabrielson, and D. W. Pack. Cyclodextrin- polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnol. Bioeng. 89, 416 (2005).
63. H. Eliyahu, A. Makovitzki, T. Azzam, A. Zlotkin, A. Joseph, and D. Gazit, Novel dextran-spermine conjugates as transfecting agents: Comparing water-soluble and micellar polymers. Gene. Ther. 12, 494 (2005).
64. J. Malmo, K. M. Varum, and S. P. Strand, Effect of chitosan chain architecture on gene delivery: Comparison of self-branched and linear chitosans. Biomacromolecules 12, 721 (2011).
65. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe, and A. P. Rolland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control Release 56, 259 (1998).
66. M. Lavertu, S. Methot, N. Tran-Khanh, and M. D. Buschmann, High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27, 4815 (2006).
67. M. Lavertu, V. Darras, and M. D. Buschmann, Kinetics and efficiency of chitosan reacetylation. Carbonhyd. Polym. 87, 1192 (2012).
68. T. Ishii, Y. Okahata, and T. C. Sato, Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514, 51 (2001).
69. Yang, X. Wang, H. Li, S. H. Goh, and J. Li, Synthesis and characterization of polyrotaxanes consisting of cationic á-cyclodextrins threaded on poly[(ethylene oxide)-ran-(propylene oxide)] as gene carriers. Biomacromolecules 8, 3365 (2007).
70. S. R. Popielarski, S. Mishra, and M. E. Davis, Structural effects of carbohydratecontaining polycations on gene delivery. 3. Cyclodextrin type and functionalization. Bioconjug. Chem. 14, 672 (2003).
71. H. Arima, F. Kihara, F. Hirayama, and K. Uekama, Enhancement of gene expression by polyamidoamine dendrimer conjugateswith α-, β-, and γ-cyclodextrins. Bioconjug. Chem. 12, 476 (2001).
72. F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, In vitro and in vivo gene transfer by an optimizedα-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug. Chem. 14, 342 (2003).
73. S. Menuel, S. Fontanay, I. Clarot, R. E. Duval, L. Diez, and A. Marsura, Synthesis and complexation ability of a novel bis- (guanidinium)-tetrakis- (β-cyclodextrin) dendrimeric tetrapod as a potential gene delivery (DNA and siRNA) system. Study of cellular siRNA transfection. Bioconjug. Chem. 19, 2357 (2008).
74. F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjug. Chem. 13, 1211 (2002).
75. H. Arima, K. Motoyama, and T. Higashi, Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors. Adv. Drug Deliver. Rev. 65, 1204 (2013).
76. C. Attilio, B. Barbara, and B. Massimiliano, Biophysical functionality in polysaccharides: From Lego-blocks to nano-particles. Eur. Biophys. J. 41, 379 (2012).
77. S. Mizrahyab and D. Peer, Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 41, 2623 (2012).
78. J. Berger, M. Reist, J. M. Mayer, O. Felt, N. A. Peppas, and R. Gurny, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 57, 19 (2004).
79. J. Berger, M. Reist, J. M. Mayer, O. Felt, and R. Gurny, Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm. 57, 35 (2004).
80. M. Bodnar, J. F. Hartmann, and J. Borbely, Preparation and characterization of chitosanbased nanoparticles. Biomacromolecules 6, 2521 (2005).
81. M. Bodnar, J. F. Hartmann, and J. Borbely, Nanoparticles from chitosan. Macromol. Symp. 227, 321 (2005).
82. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, and Z. Zhang, Polysaccharidesbased nanoparticles as drug delivery systems. Adv. Drug Delivery 60, 1650 (2008).
83. A. Bernkop-Schnurch, C. E. Kast, and M. F. Richter, Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control Release 71, 277 (2001).
84. K. Akiyoshi, S. Kobayashi, S. Shichibe, D. Mix, M. Baudys, S. W. Kim, and J. Sunamoto, Self assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J. Control Release 54, 313 (1998).
85. M. Gupta and A. K. Gupta, Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J. Control Release 99, 157 (2004).
86. P. Calvo, C. RemunanLopez, J. L. VilaJato, and M. J. Alonso, Novel hydrophilic chitosanpolyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63, 125 (1997).
87. P. Calvo, C. RemunanLopez, J. L. VilaJato, and M. J. Alonso, Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14, 1431 (1997).
88. D. Jain and R. Banerjee, Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J. Biomed. Mater. Res. A 86B, 105 (2008).
89. N. Csaba, M. Koping-Hoggard, and M. J. Alonso, Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 382, 205 (2009).
90. Y. Sun and A. J. Wan, Preparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromolecules. J. Appl. Polym. Sci. 105, 552 (2007).
91. Y. M. Xu, Y. M. Du, R. H. Huang, and L. P. Gao, Preparation and modification of N -(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 24, 5015 (2003).
92. M. Amidi, S. G. Romeijn, G. Borchard, H. E. Junginger, W. E. Hennink, and W. Jiskoot, Preparation and characterization of protein-loaded N -trimethyl chitosan nanoparticles as nasal delivery system. J. Control Release 111, 107 (2006).
93. J. O. You and C. A. Peng, Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol. Symp. 219, 147 (2004).
94. A. Zahoor, S. Sharma, and G. K. Khuller, Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Ag. 26, 298 (2005).
95. J. H. Hamman, Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems. Mar. Drugs 8, 1305 (2010).
96. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug. Delivery Rev. 62, 28 (2010).
97. Z. R. Cui and R. J. Mumper, Chitosan-based nanoparticles for topical genetic immunization. J. Control Release 75, 409 (2001).
98. Y. Chen, V. J. Mohanraj, and J. E. Parkin, Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Lett. Pept. Sci. 10, 621 (2003).
99. W. Tiyaboonchai and N. Limpeanchob, Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int. J. Pharm. 329, 142 (2007).
100. B. Sarmento, S. Martins, A. Ribeiro, F. Veiga, R. Neufeld, and D. Ferreira, Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int. J. Pept. Res. Ther. 12, 131 (2006).
101. B. Sarmento, A. Ribeiro, F. Veiga, and D. Ferreira, Development and characterization of new insulin containing polysaccharide nanoparticles. Colloid Surface B 53, 193 (2006).
102. B. Sarmento, D. Ferreira, F. Veiga, and A. Ribeiro, Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pregelation through DSC and FTIR studies. Carbohydr. Polym. 66, 1 (2006).
103. Z. H. Liu, Y. P. Jiao, F. Liu, and Z. Y. Zhang, Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. J. Biomed. Mater. Res. A 83, 806 (2007).
104. Y. H. Lin, C. K. Chung, C. T. Chen, H. F. Liang, S. C. Chen, and H. W. Sung, Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6, 1104 (2005).
105. S. J. Shu, X. Wang, X. Zhang, X. J. Zhang, Z. Wang, and C. X. Li, Disulfide cross-linked biodegradable polyelectrolyte nanoparticles for the oral delivery of protein drugs. New J. Chem. 33, 1882 (2009).
106. K. Sonaje, Y. H. Lin, J. H. Juarng, S. P. Wey, C. T. Chen, and H. W. Sung, In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30, 2329 (2009).
107. M. Jean, F. Smaoui, M. Lavertu, S. Methot, L. Bouhdoud, M. D. Buschmann, and A. Merzouki, Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies. Gene. Ther. 16, 1097 (2009).
108. S. P. Strand, S. Lelu, N. K. Reitan, C. de Lange Davies, P. Artursson, and K. M. Varum, Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking. Biomaterials 31, 975 (2010).
109. M. Koping-Hoggard, K. M. Varum, M. Issa, S. Danielsen, B. E. Christensen, B. T. Stokke, and P. Artursson, Improved chitosanmediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11, 1441 (2004).
110. S. Sajeesh and C. P. Sharma, Novel pH responsive polymethacrylic acid-chitosanpolyethylene glycol nanoparticles for oral peptide delivery. J. Biomed. Mater. Res. B 76, 298 (2006).
111. Q. Chen, Y. Hu, Y. Chen, X. Q. Jiang, and Y. H. Yang, Microstructure formation and property of chitosan-poly(acrylic acid) nanoparticles prepared by macromolecular complex. Macromol. Biosci. 5, 993 (2005).
112. M. I. Giannotti, O. Esteban, M. Oliva, M. F. García-Parajo, and F. Sanz, pH-Responsive Polysaccharide-Based Polyelectrolyte Complexes As Nanocarriers for Lysosomal Delivery of Therapeutic Proteins. Biomacromolecules 12, 2524 (2011).
113. C. Allen, D. Maysinger, and A. Eisenberg, Nano-engineering block copolymer aggregates for drug delivery. Colloid Surface B 16, 3 (1999).
114. K. Letchford and H. Burt, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65, 259 (2007).
115. J. H. Kim, Y. S. Kim, K. Park, E. Kang, S. Lee, H. Y. Nam, K. Kim, J. H. Park, D. Y. Chi, R. W. Park, I. S. Kim, K. Choi and I. C Kwon, Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 29, 1920 (2008).
116. Q. Li, C. G. Liu, Z. H. Huang, F. F. Xue, Preparation and characterization of nanoparticles based on hydrophobic alginate derivative as carriers for sustained release of Vitamin D3 . J. Agric. Food Chem. 59, 1962 (2011).
117. K. Y. Choi, H. Chung, K. H. Min, H. Y. Yoon, K. Kim, J. H. Park, I. C. Kwon, and S. Y. Jeong, Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31, 106 (2010).
118. K. K. Upadhyay, A. N. Bhatt, A. K. Mishra, B. S. Dwarakanath, S. Jain, C. Schatz, J. F. Meins, A. Farooque, G. Chandraiah, A. K. Jain, A. Misra, and S. Lecommandoux, The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(ã-benzyl L-glutamate)-b-hyaluronan polymersomesSelf-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31, 2882 (2010).
119. S. Hornig, H. Bunjes, and T. Heinze, Preparation and characterization of nanoparticles based on dextran-drug conjugates. J. Colloid Interf. Sci. 338, 56 (2009).
120. M. E. Davis and M. E. Brewster, Cyclodextrin-based pharmaceutics: Past, present and future. Nat. Rev. Drug Discovery 3, 1023 (2004).
121. M. R. Rekha and C. P. Sharma, Pullulan as a promising biomaterial for biomedical applications: A perspective. Trends Biomater. Artif. Organs. 20, 116 (2007).
122. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Delivery Rev. 62, 28 (2010).
123. S. Y. Park, H. J. Baik, Y. T. Oh, K. T. Oh, Y. S. Youn, and E. S. Lee, A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem. Int. Edit. 50, 1644 (2011).
124. T. Pouyani and G. D. Prestwich, Functionalized derivatives of hyaluronic acid oligosaccharides: Drug carriers and novel biomaterials. Bioconjugate Chem. 5, 339 (1994).
125. M. B. Duncan, M. Liu, C. Fox, and J. Liu, Characterization of the N -deacetylase domain from the heparan sulfate N -deacetylase/Nsulfotransferase 2. Biochem. Biophys. Res. Commun. 339, 1232 (2006).
126. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler, Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Bioph. Res. Co. 353, 26 (2007).
127. V. M. Platt and F. C. Szoka, Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol. Pharmacol. 5, 474 (2008).
128. C. Lemarchand, R. Gref, and P. Couvreur, Polysaccharidedecorated nanoparticles. Eur. J. Pharm. Biopharm. 58, 327 (2004).
129. C. Dombu, R. Carpentier, and D. Betbeder, Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells. Biomaterials 33, 9117 (2012).
130. I. A. Khalil, K. Kogure, H. Akita, and H. Harashima, Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. 58, 32 (2006).
131. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji, A review of stimuliresponsive nanocarriers for drug and gene delivery. J. Control Release 126, 187 (2008).
132. P. J. Murray and T. A. Wynn, Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723 (2012).
133. G. Virella (ed.), Medical Immunology, Sixth edn., Medical University of South Carolina Charleston, South Carolina, USA (2007).
134. H. Hillaireau and P. Couvreur, Nanocarriers' entry into the cell: Relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873 (2009).
135. D. Labarre, The interactions between blood and polymeric nanoparticles depend on the nature and structure of the hydrogel covering the surface. Polymers 4, 986 (2012).
136. K. Bergström, E. Osterberg, K. Holmberg, A. S. Hoffman, T. P. Schuman, A. Kozlowski, and J. H. Harris, Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. J. Biomater. Sci. Polym. Ed. 6, 123 (1994).
137. E. Osterberg, K. Bergström, K. Holmberg, T. P. Schuman, J. A. Riggs, N. L. Burns, J. M. Van Alstine, and J. M. Harris, Proteinrejecting ability of surface-bound dextran in end-on and side-on configurations: Comparison to PEG. J. Biomed. Mater. Res. 29, 741 (1995).
138. I. Bertholon, C. Vauthier, and D. Labarre, Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length and type of polysaccharide. Pharm Res-Dordr. 23, 1313 (2006).
139. J. J. Shi, A. R. Votruba, O. C. Farokhzad, and R. Langer, Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett. 2010, 3223 (2010).
140. Y. Pathak and D. Thassu (eds.), Drug Delivery Nanoparticles Formulation and Characterization, Information Healthcare Publisher, New York (2009).
141. C. Chauvierre, D. Labarre, P. Couvreur, and C. Vauthier, Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm. Res. 20, 1786 (2003).
142. R. G. McQuire, D. Green, D. Walsh, S. Hall, J. Y. Chane-Ching, R. O. Oreffo, and S. Mann, Fabrication of hydroxyapatite sponges by dextran sulphate/amino acid templating.Biomaterials 26, 6652 (2005).
143. F. Talaei, M. Azhdarzadeh, H. H Nasel, M. Moosavi, A. Foroumadi, R. Dinarvand, and F. Atyabi, Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation. Drau 19, 257 (2011).
144. R. Haag and F. Kratz, Polymer therapeutics: Concepts and applications. Angew. Chem. Int. Ed. 45, 1198 (2006).
145. S. Soh, M. Byrska, K. Kandere-Grzybowska, and B. A. Grzybowski, Reaction-diffusion systems in intracelluar molecular transport and control. Angew. Chem. Int. Edit. 49, 4179 (2010).
146. A. K. Jain, S. K. Jain, and K. B. Chalasani, Non-invasive stystemic delivery of proteins(s) and peptide(s). Pharmagazene 1, 73 (2013).
147. M. Chaturvedi, M. Kumar, and K. Pathak, A review on mucoadhesive polymer used in nasal drug delivery system. J. Adv. Pharm. Technol. Res. 2, 215 (2011).
148. A. Fasano, Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation. Am. J. Pathol. 173, 1243 (2008).
149. C. Y. Dombu, M. Kroubi, R. Zibouche, R. Matran, and D. Betbeder, Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells. Nanotechnology 21, 1 (2010).
150. M. Thomas and A. M. Klibanov, Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. PNAS 99, 14640 (2002).
151. A. B. Foraker, B. S. Characacterization of the Endocytic Pathways Regulating Riboflavin (vitamin B2) Absorption and Trafficking in Human Epithelial Cells, Degree Doctor of Philosophy in the Graduate School of The Ohio State University (2007).
152. S. Febvay, D. M. Marini, A. M. Belcher, and D. E. Clapham, Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. Nano Lett. 10, 2211 (2010).
153. L. Pelkmans, E. Fava, H. Grabner, M. Hannus, B. Habermann, E. Krausz, and M. Zerial, Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78 (2005).
154. J. E. Schnitzer, P. Oh, E. Pinney, and J. Allard, Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127, 1217 (1994).
155. H. Hillaireau and P. Couvreur, Nanocarrier's entry into the cell: Relevance to drug delicery. Cell Mol. Life Sci. 66, 2873 (2009).
156. H. Meng, M. Liong, T. Xia, Z. Li, Z. Ji, J. I. Zink, and A. E. Nel, Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4, 4539 (2010).
157. Z. Cheng, A. A Zaki, J. Z. Hui, V. R. Muzykantov, and A. Tsourkas, Multifunctional nanoparticles: Cost versus benefit of adding targeting and imaging capabilities. Science 338, 903 (2012).
158. S. Mao, O. Germershaus, D. Fischer, T. Linn, R. Schnepf and T. Kissel, Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res. 22, 2058 (2005).
159. S. Mitragotri and J. Lahann, physical approaches to biomaterial design. Nat Mater. 8, 15 (2009).
160. S.E. Gratton, P. A. Ropp, P. D. Pohlaus, J. C. Luft, V. J. Madden, M. E. Napier, and J. M. DeSimone, The effect of particle design on cellular internalization pathways. Proc. Nati. Acad. Sci. USA 105, 11613 (2008).
161. D. E. Meyer, B. C. Shin, G. A. Kong, M. W. Dewhirst, and A. Chilkoti, Drug targeting using thermally esponsive polymers and local hyperthermia. J. Control Release 74, 213 (2001).
162. J. F. Mano, Stimuli-responsive polymeric systems for biomedical applications. Adv. Eng. Mater. 10, 515 (2008).
163. S. Sun, W. Liu, N. Cheng, B. Zhang, Z. Cao, K. Yao, D. Liang, A. Zuo, G. Guo, and J. Zhang, A thermoresponsive chitosan-NIPAAm/vinyl laurate copolymer vector for gene transfection. Bioconjug. Chem. 16, 972 (2005).
164. H. Jung, S. H. Heo, J. P. Nam, D. G. Kim, Y. I Jeong, Y. B. Kim, M. K. Jang, and J. W. Nah, Temperature sensitive drug delivery system using PNIP AAM and Chitosan, Appl. Chem. 13, 29 (2009).
165. J. Jiang, D. Hua, and J. Tang, One-pot synthesis of pH- and thermo-sensitive chitosan-based nanoparticles by the polymerization of acrylic acid/chitosan with macro-RAFT agent. Int. J. Biol. Macromol. 46, 126 (2010).
166. N. Morimoto, X. P. Qiu, F. M. Winnik, and K. Akiyoshi, Dual stimuli-responsive nanogels by self-assembly of polysaccharides lightly grafted with thiol-terminated poly(N -isopropylacrylamide) chains. Macromolecules 41, 5985 (2008).
167. M. Bikram and J. L. West, Thermo-responsive systems for controlled drug delivery. Expert Opin. Drug Del. 5, 1077 (2008).
168. K. C. Gupta and M. Kumar, Drug release behavior of beads and microgranules of chitosan. Biomaterials 21, 1115 (2000).
169. K. C. Gupta and M. Kumar, Preparation, characterization and release profiles of pH-sensitive chitosan beads. Polym. Int. 49, 141 (2000).
170. K. C. Gupta and M. Kumar, Semi-interpenetrating polymer network beads of crosslinked chitosan-glycine for controlled release of chlorphenramine maleate. J. Appl. Polym. Sci. 76, 672 (2000).
171. M. I. Giannotti, O. Esteban, M. Oliva, M. F. García-Parajo, and F. Sanz, pH-Responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. Biomacromolecules 12, 2524 (2011).
172. A. Suzuki and T. Tanaka, Hase transition in polymer gels induced by visible light. Nature 345-347 (1990).
173. K. Sumaru, M. Kameda, T. Kanamori, and T. Shinbo, Characteristic phase transition of aqueous solution of poly(Nisopropylacrylamide) functionalized with spirobenzopyran. Macromolecules 37, 4949 (2004).
174. J. Edahiro, K. Sumaru, T. Takagi, T. Shinbo, and T. Kanamori, Photoresponse of an aqueous two-phase system composed of photochromic dextran. Langmuir 22, 5224 (2006).
175. A. Lendlein, H. Jiang, O. Jünger, and R. Langer, Light-induced shape-memory polymers. Nature 434, 879 (2005).
176. H. Jiang, S. Kelch, and A. Lendlein, Polymers move in response to light. Adv. Mater. 18, 1471 (2006).
177. B. P. Lisa and O. B James, Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 64, 206 (2012).
178. W. She, K. Luo, C. Zhang, G. Wang, Y. Geng, L. Li, B. He, and Z. Gu, The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendronedoxorubicin conjugates for cancer therapy. Biomaterials 34, 1613 (2013).
179. B. Lu, S. B. Xiong, H. Yang, X. D. Yin, and R. B. Zhao, Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases II: Tissue distribution and pharmacodynamics. Int. J. Pharmaceut. 307, 175 (2006).
180. K. Na, T. B. Lee, K. H. Park, E. K. Shin, Y. B. Lee, and H. K. Choi, Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18, 165 (2003).
181. S. Mitraa, U. Gaura, P. C. Ghosha, and A. N. Maitra, Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control Release 74, 317 (2001).
182. E. K. Lim, S. Warayuth, Y. N. Choi, E. J. Jang, H. J. Lee, and B. H. Kang, Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy. Nano Res. Letl. 8, 467 (2013).
183. J. H. Na, H. Koo, and S. Lee, Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 32, 5252 (2011).
184. J. H. Kim, S. M. Bae, M. H. Na, H. L. Shin, Y. J. Yang, K. H. Min, K. Y. Choi, K. M. Kim, R. W. Park, I. C. Kwon, B. H. Lee, A. S. Hoffman, and In-San Kim, Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues. J. Control Release 157, 493 (2012).
185. V. M. Platt and F. C. Szoka, Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol. Pharm. 5, 474 (2008).
186. A. Sugunana, C. Thanachayanontb, J. Duttaa, and J. G. Hilborn, Heavy-metal ion sensors using chitosan-capped gold nanoparticles. Sci. Technol Adv. Mat. 6, 335 (2005).
187. B. Krajewska, Application of chitin-and chitosan-based materials for enzyme immobilization: A review. Enzyme Microb. Technol. 35, 126 (2004).
188. S. E. Bailey, T. J. Olin, R. M. Bricka, and D. D. Adrian, A review of potentially low-cost sorbants for heavy metals. Water Resour. Manag. 33, 2469 (1999).
189. E. Guibal, Interactions of metal ions with chitosan-based sorbents: A review. Sep. Purif. Technol. 38, 43 (2004).
190. E. I. Rabea, M. E. T. Badawy, C. V. Stevens, G. Smagghe, and W. Steurbaut, Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 4, 1457 (2003).
191. W. Ament, J. R. Huizenga, E. Kort, T. W. Van Der Mark, R. G. Grevink, and G. J. Verkerke, Respiratory ammonia output and blood ammonia concentration during incremental exercise. Int. J. Sports Med. 20, 71 (1999).
192. L. R. Narasimhan, W. Goodman, and N. Patel, Correlation of breath ammo-nia with blood urea nitrogen and creatinine during hemodialysis. Proc. Nat. Acad. Sci. USA 98, 4617 (2001).
193. S. Pandey, G. K. Goswami, and K. K. Nanda, Green synthesis of polysaccharide/gold nanoparticle nanocomposite: An efficient ammonia sensor. Carbohyd. Polym. 94, 229 (2013).
194. K. Kerman, M. Saito, and E. Tamiya, Electroactive chitosan nanoparticles for the detection of single-nucleotide polymorphisms using peptide nucleic acids. Anal. Bioanal. Chem. 391, 2759 (2008).
195. J. Kong, A. R. Ferhan, X. Chen, L. Zhang, and N. Balasubramanian, Polysaccharide template silver nanowire for ultrasensitive electrical detection of nucleic acids. Anal. Chem. 80, 7213 (2008).
196. M. L. P. V. Baptista, Gold and silver nanoparticles for clinical diagnostics - From genomics to proteomics. J. Proteomics 75, 2811 (2012).
197. K. Kerman, M. Saito, and Tamiya, Electroactive chitosan nanoparticles for the detection of single-nucleotide polymorphisms using peptide nucleic acids. Anal. Bioanal. Chem. 391, 2759 (2008).
198. K. Kerman, M. Saito, and E. Tamiya, Electroactive chitosan nanoparticles for the detection of single-nucleotide polymorphisms using peptide nucleic acids. Anal Bioanal. Chem. 391, 2759 (2008).
199. W. Suginta, P. Khunkaewla, and A. Schulte, Electrochemical biosensor applications of polysaccharides chitin and chitosan. Chem. Rev. 113, 5458 (2013).